Position in SRRK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$847,673,351
+$170,154,619 QoQ
Shares Held
17,243,152
+12.1% QoQ
Ownership
14.4%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99390482668133.ToString("F0")%
Shared 0.ToString("F0")%
None 0.0060951733186600686.ToString("F0")%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,674,888,413 across 352 Biotechnology names. SRRK ranks #17 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in SRRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $847,673,351 | 17,243,152 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $677,518,732 | 15,380,675 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $521,809,784 | 14,012,078 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $490,031,270 | 13,834,875 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $443,492,852 | 13,794,490 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $589,315,979 | 13,635,261 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $81,670,327 | 10,196,046 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $82,360,650 | 9,887,233 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $188,298,214 | 10,602,377 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $195,793,257 | 10,414,535 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $56,840,142 | 8,005,654 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $58,167,313 | 7,714,498 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $58,948,472 | 7,368,559 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $66,248,776 | 7,320,307 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $50,706,081 | 7,316,895 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $40,158,806 | 7,314,901 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $68,259,058 | 5,295,505 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $130,812,878 | 5,266,219 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $170,683,317 | 5,169,089 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $149,190,469 | 5,162,300 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $260,362,307 | 5,139,406 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $244,873,837 | 5,045,824 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $79,272,481 | 4,481,203 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $81,600,539 | 4,481,084 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $54,146,546 | 4,471,226 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||